The Antibody Society has partnered with numerous conference organizers, including Informa Connect, Cambridge Healthtech Institute, Hanson Wade, and Terrapinn, to ensure our members receive substantial discounts on meeting registration fees. As a courtesy, we also list meetings held by non-profit organizations, such as Gordon Research Conferences and KeyStone Symposia.
In 2022, we have also partnered with Schrödinger, and are pleased to offer 10% discounts to our members for their online course, Introduction to Computational Antibody Engineering.
Schrödinger’s online course, Introduction to Computational Antibody Engineering, will show how industry-leading computational molecular modeling solutions are used to aid in antibody discovery and design and how to incorporate these computational approaches into your research project. This course will also provide a chance to work hands-on with Schrödinger’s BioLuminate software.
Upcoming 2022 Session Dates:
September 12th, 10:00 AM ET – October 19th, 4:59 PM ET
November 7th, 10:00 AM ET – December 14th, 4:59 PM ET
The Antibody Society members save 10% off your booking – contact membership@antibodysociety.org for the discount code. With no discount, the course fee is $475 for non-student users and $350 for student users.
August 2022
Join industry pioneers revolutionizing antibodies, linkers and payloads from data driven research for this one-day digital event!
The Antibody Society is an official media partner for Antibody Drug Conjugates 2022. This brand-new virtual event taking place on August 10, 2022, brings you a must-see line-up of industry names that you won’t want to miss.
What you can expect:
- Gain an understanding of toxicity mechanisms to improve safety and reduce off-target effects
- Learn improved approaches for intelligent drug design strategy
- Identify novel tumor targets to broaden the scope and improve the therapeutic outcome for ADC drugs
- Recognize rapid characterization methods to identify and investigate new bioconjugation sites
Don’t miss out! See the full agenda and learn more here.
Register here – Save £400 with early bird pricing and secure your place for only £399 if you book before midnight Friday July 22.
Secure your place today with an extra 15% discount – contact membership@antibodysociety.org for the discount code.
September 2022
13th Annual World ADC San Diego (September 6-9)
Running for the first time in-person since 2019, the hotly anticipated 13th World ADC San Diego is back, bigger and better than ever before.
With a continued dedication to curating scientific insights and transformative lessons to maximizing the clinical therapeutic index of your ADC, this year’s meeting delves further into the resurgence of ADCs being used as combination therapies, next generation payloads, and how to evolve your manufacturing processes in this fast-paced and ever-evolving field.
As your global one stop shop for antibody drug conjugates from early discovery to late phase manufacturing, join AstraZeneca, Genentech, Mersana Therapeutics, Sutro Biopharma, Daiichi Sankyo and many more to gain updates from the dynamic nonclinical and clinical environment.
Access your copy of brand-new full event guide with 100+ world class speakers.
This is your ultimate platform to meet face-to-face with 600+ pioneers at the forefront of ADC R&D and foster vital scientific exchange and communication to propel these life-saving therapeutics to more patients now.
To join our longstanding ADC community in sunny San Diego, register your place here.
Antibody Society members save 10% on their booking – contact membership@antibodysociety.org for the discount code.
13th Annual World Multispecifics Summit
September 20 – 22, 2022 | Boston, MA
The Newly Re-Branded 13th World Multispecifics Summit returns this September as the only end-to-end meeting committed solely to advancing the development of bi- & multi-specific therapeutics.
This world-renowned forum will deliver a greater scope and penetration of innovative technical content than any other meeting. This year’s re-imagined agenda will cover unique target discovery, mechanistic diversity and translational science as well as novel formats, product design and manufacturability challenges faced in the bispecific field.
Download the full event guide here
Whatever your role or interest, you will leave the meeting with concrete methods to employ in your strategy and pipeline to convert the promise of bi- and multi-specific therapeutics into a reality for patients.
Early bird and group discounts available – see the pricing information here.
Antibody Society members save 10% on their booking – contact membership@antibodysociety.org for the discount code.
Next Generation Protein Therapeutics Summit returns to Boston, September 28 – 30, 2022.
This is your opportunity to network with like-minded peers in the industry who are looking at the cutting-edge research on the next generation of proteins and molecules. Swap tips and business cards with pioneers in the field and dive into the critical insights that will pave the way for your next break-through.
Dive into critical topics, including:
- Bioconjugate Design and Challenges
- Multispecific Design and Challenges
- T Cell Engager Design and Challenges
- Engineering and Designing Scaffolds As Therapeutics
- Protein Engineering Techniques and
- Workflows for Improved Protein Design
- New Targets & Target Specificity
- Solutions for Unmet Drug Delivery Challenges
- Clinical Progress for Beyond Antibodies
- AI/ML & Next Generation Sequencing for the Future of Protein Engineering & Design
Get 15% off as an Antibody Society member! Contact membership@antibodysociety.org for the discount code.
December 2022
Join us in San Diego for the next Antibody Engineering & Therapeutics meeting!
Dive into brand new topic streams in 2022 that will cover key areas in industry:
- Antibody engineering, libraries and selection (including HTS)
- Machine learning/artificial intelligence in antibody discovery and engineering
- Fc-engineering & other (non IgG1/IgG4) subclasses
- Antibody-drug conjugates
- Advancing antibody therapeutics in immuno-oncology
- Tumor microenvironment (including immunocytokines)
- Novel/difficult targets for antibody therapeutics (e.g. MHCp, GPRC, glycans)
- How to develop an antibody-based drug: from discovery to IND?
- Adaptive immune receptor repertoire data processing, annotation and interpretation
- Antibodies in non-cancer (Autoimmune, neurological and other diseases)
- Functional Screening Integrated Into Initial Antibody Discovery
- Antibody-drug conjugates, toxins and other conjugates
- Cellular therapies: CART’s (T and NK) (non-cell engaging)
- Bispecifics / multispecifics / combinations (non-cell engaging)
- Antibodies in Infectious diseases
- T cell (including gamma/delta) and NK cell engagers
Don’t miss out! See the full agenda and learn more here.
